X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://blog.petrieflom.law.harvard.edu/2020/06/05/vioxx-rofecoxib-orphan-drug/
https://www.biospace.com/article/6-major-drug-recalls-in-the-past-for-health-concerns/?s=95
https://www.biospace.com/article/mass-pharma-company-aims-to-give-new-life-to-shelved-arthritis-drug-vioxx/
https://www.forbes.com/sites/matthewherper/2018/10/24/fda-experts-may-reconsider-diabetes-drug-safety-rules/#2e4c1b2a76d7
http://www.pharmatimes.com/news/study_links_nsaids_with_higher_risk_of_cardiac_arrest_1189035
http://www.fiercepharma.com/pharma/trump-pharma-look-for-ways-to-reshape-u-s-drug-industry
http://www.wsj.com/articles/study-suggests-celebrex-isnt-riskier-than-rival-pain-drugs-1479073501
http://www.fiercepharma.com/pharma/already-facing-200m-damages-j-j-seeks-to-move-talc-cases-out-st-louis
http://www.reuters.com/article/us-health-nsaids-heart-failure-idUSKCN12K2J1
http://www.reuters.com/article/us-pfizer-lawsuit-idUSKCN0X91SF
http://www.forbes.com/sites/ritarubin/2016/03/18/tylenol-not-effective-for-arthritis-pain-study-concludes-and-other-drugs-arent-exactly-winners/#469b8b4517c8
http://www.fiercepharma.com/story/merck-reaches-830m-settlement-long-running-vioxx-litigation/2016-01-15
http://www.forbes.com/sites/johnlamattina/2015/09/02/uk-study-indicates-that-the-cardiovascular-risk-of-celebrex-no-different-from-other-pain-drugs/
http://www.fdanews.com/articles/170849-ema-wants-updated-advice-on-cv-risk-of-high-dose-ibuprofen
http://www.9news.com.au/national/2015/02/26/10/50/vioxx-settlement-approved-by-fed-court
http://www.forbes.com/sites/larryhusten/2015/02/24/common-pain-drugs-linked-to-more-problems-after-a-heart-attack/
Market Place
Share 
